San Segundo, D.; Arnáiz de las Revillas, F.; Lamadrid-Perojo, P.; Comins-Boo, A.; González-Rico, C.; Alonso-Peña, M.; Irure-Ventura, J.; Olmos, J.M.; Fariñas, M.C.; López-Hoyos, M.
Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients. Biomedicines 2021, 9, 917.
https://doi.org/10.3390/biomedicines9080917
AMA Style
San Segundo D, Arnáiz de las Revillas F, Lamadrid-Perojo P, Comins-Boo A, González-Rico C, Alonso-Peña M, Irure-Ventura J, Olmos JM, Fariñas MC, López-Hoyos M.
Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients. Biomedicines. 2021; 9(8):917.
https://doi.org/10.3390/biomedicines9080917
Chicago/Turabian Style
San Segundo, David, Francisco Arnáiz de las Revillas, Patricia Lamadrid-Perojo, Alejandra Comins-Boo, Claudia González-Rico, Marta Alonso-Peña, Juan Irure-Ventura, JosĂ© Manuel Olmos, MarĂa Carmen Fariñas, and Marcos LĂłpez-Hoyos.
2021. "Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients" Biomedicines 9, no. 8: 917.
https://doi.org/10.3390/biomedicines9080917
APA Style
San Segundo, D., Arnáiz de las Revillas, F., Lamadrid-Perojo, P., Comins-Boo, A., González-Rico, C., Alonso-Peña, M., Irure-Ventura, J., Olmos, J. M., Fariñas, M. C., & López-Hoyos, M.
(2021). Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients. Biomedicines, 9(8), 917.
https://doi.org/10.3390/biomedicines9080917